Hengrui Pharma (600276.SH): HRS-4642 Injection has been included in the list of breakthrough therapies. Currently, no similar drugs have been approved for marketing domestically or internationally.

Hengrui Pharma (600276.SH) announced that recently, its HRS-4642 injection has been included in the list of breakthrough therapies by the Center for Drug Evaluation of the National Medical Products Administration. Proposed indication (or function): This product, in combination with gemcitabine and nab-paclitaxel, is intended for first-line treatment of advanced or metastatic pancreatic cancer carrying the KRAS G12D mutation.

Zhitong FinanceFeb 6 17:47

ZHITONG AH Statistics | February 9

AH Statistics | February 9

Zhitong Finance16:15

HKG Announcement Insight | Montage Technology priced at HKD 106.89 per share, with the Hong Kong public offering receiving 707.3 times subscription.

Zijin Mining (02899) announced its production planning for key mineral products from 2026 to 2028 and the outline of long-term goals up to 2035; CRRC Times Electric (03898) is projected to achieve a net profit attributable to shareholders of approximately 4.105 billion yuan in 2025, representing a year-on-year increase of 10.88%.

Zhitong Finance08:56

National Large Fund Plans to Reduce Stake in Semiconductor Sub-sector Leader! Maximum of 3% Shares | Post-market Announcement Highlights

A dark horse in the photovoltaic sector has obtained a key 'license,' the leading innovator in pharmaceuticals has received another favorable development, while a semiconductor silicon wafer leader has unexpectedly faced a reduction in holdings by the National Integrated Circuit Industry Investment Fund...

Golden10 DataFeb 6 20:56

Breaking: This company has been investigated by the CSRC for suspected violations of information disclosure regulations | Post-market announcement highlights

Yahui Long: Suspected of Violations and Irregularities in Information Disclosure, Investigated by the CSRC

cls.cnFeb 6 20:17

Zhitong HKEX Short Position Statistics | February 6

Zhitong HK Stock Short Position Report | February 6

Zhitong FinanceFeb 6 18:30